bluebird bio, Inc. Interest Expense
bluebird bio, Inc. reported Interest Expense of $4.86 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-09-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-11-14
- bluebird bio, Inc. interest expense for the quarter ending 2024-03-31 was $4.86M, a 13.72% increase year-over-year.
- bluebird bio, Inc. interest expense for the quarter ending 2023-12-31 was $4.02M.
- bluebird bio, Inc. interest expense for the quarter ending 2023-09-30 was $4.31M.
- bluebird bio, Inc. interest expense for the quarter ending 2023-06-30 was $3.75M.
- bluebird bio, Inc. interest expense for fiscal 2023 was $16.35M, a 158.67% increase from fiscal 2022.
- bluebird bio, Inc. interest expense for fiscal 2022 was $6.32M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $4.86M 10-Q · filed 2024-09-13 | $8.88M derived: sum of 2 quarters · filed 2024-09-13 | $13.19M derived: sum of 3 quarters · filed 2024-11-14 | $16.94M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-12-31 | $4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-13 | $8.33M derived: sum of 2 quarters · filed 2024-11-14 | $12.08M derived: sum of 3 quarters · filed 2024-11-14 | $16.35M 10-K · filed 2024-09-13 |
| 2023-09-30 | $4.31M 10-Q · filed 2024-11-14 | $8.06M derived: sum of 2 quarters · filed 2024-11-14 | $12.33M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $3.75M 10-Q · filed 2024-09-27 | $8.02M 10-Q · filed 2024-09-27 | ||
| 2023-03-31 | $4.27M 10-Q · filed 2024-09-13 | |||
| 2022-12-31 | $6.32M 10-K · filed 2024-09-13 |